Amos Bar-shalev - Net Worth and Insider Trading
Amos Bar-shalev Net Worth
The estimated net worth of Amos Bar-shalev is at least $193 dollars as of 2024-04-27. Amos Bar-shalev is the Director of Protalix BioTherapeutics Inc and owns about 168 shares of Protalix BioTherapeutics Inc (PLX) stock worth over $193. Details can be seen in Amos Bar-shalev's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Amos Bar-shalev has not made any transactions after 2009-12-02 and currently still holds the listed stock(s).
Transaction Summary of Amos Bar-shalev
Amos Bar-shalev Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Amos Bar-shalev owns 1 companies in total, including Protalix BioTherapeutics Inc (PLX) .
Click here to see the complete history of Amos Bar-shalev’s form 4 insider trades.
Insider Ownership Summary of Amos Bar-shalev
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2020-01-20 | director |
Amos Bar-shalev Latest Holdings Summary
Amos Bar-shalev currently owns a total of 1 stock. Amos Bar-shalev owns 168 shares of Protalix BioTherapeutics Inc (PLX) as of December 2, 2009, with a value of $193.
Latest Holdings of Amos Bar-shalev
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2009-12-02 | 168 | 1.15 | 193 |
Holding Weightings of Amos Bar-shalev
Amos Bar-shalev Form 4 Trading Tracker
According to the SEC Form 4 filings, Amos Bar-shalev has made a total of 0 transactions in Protalix BioTherapeutics Inc (PLX) over the past 5 years. The most-recent trade in Protalix BioTherapeutics Inc is the acquisition of 168 shares on December 2, 2009, which cost Amos Bar-shalev around $14,263.
Insider Trading History of Amos Bar-shalev
- 1
Amos Bar-shalev Trading Performance
GuruFocus tracks the stock performance after each of Amos Bar-shalev's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amos Bar-shalev is -6.69%. GuruFocus also compares Amos Bar-shalev's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amos Bar-shalev within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Amos Bar-shalev's insider trading performs compared to the benchmark.
Performance of Amos Bar-shalev
Average Return
11.58%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.8 | -6.69 | -13.64 | 11.58 | -11.18 | -10.62 |
| Relative Return to S&P 500(%) | -15.33 | -7.51 | -12.66 | 1.46 | -17.09 | -19.11 |
Amos Bar-shalev Ownership Network
Ownership Network List of Amos Bar-shalev
Ownership Network Relation of Amos Bar-shalev
Amos Bar-shalev Owned Company Details
What does Protalix BioTherapeutics Inc do?
Who are the key executives at Protalix BioTherapeutics Inc?
Amos Bar-shalev is the director of Protalix BioTherapeutics Inc. Other key executives at Protalix BioTherapeutics Inc include director & President and CEO Dror Bashan , 10 percent owner Dexcel Pharma Technologies Ltd. , and 10 percent owner Dan Oren .
Protalix BioTherapeutics Inc (PLX) Insider Trades Summary
Over the past 18 months, Amos Bar-shalev made no insider transaction in Protalix BioTherapeutics Inc (PLX). Other recent insider transactions involving Protalix BioTherapeutics Inc (PLX) include a net purchase of 110,000 shares made by Aharon Schwartz , and a net purchase of 64,516 shares made by Dror Bashan .
In summary, during the past 3 months, insiders sold 0 shares of Protalix BioTherapeutics Inc (PLX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protalix BioTherapeutics Inc (PLX) were sold and 174,516 shares were bought by its insiders, resulting in a net purchase of 174,516 shares.
Protalix BioTherapeutics Inc (PLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protalix BioTherapeutics Inc Insider Transactions
Amos Bar-shalev Mailing Address
Above is the net worth, insider trading, and ownership report for Amos Bar-shalev. You might contact Amos Bar-shalev via mailing address: C/o Protalix Biotherapeutics, Inc., 2 Snunit St, Science Park, Pob 455, Carmiel L3 20100.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
